Fibroadenoma: A Benign Breast Lesion
A fibroadenoma is the most common benign breast tumor, typically presenting as a smooth, rubbery, mobile mass that predominantly affects young women under the age of 40. 1
Clinical Characteristics
Presentation:
- Smooth, rubbery, mobile mass on palpation
- Usually painless
- Typically unilateral
- Most common in women under 40 years of age
- May enlarge during pregnancy or hormonal changes 2
Physical Examination Findings:
- Well-circumscribed
- Mobile ("breast mouse" - moves freely within breast tissue)
- Firm consistency
- Usually 1-3 cm in diameter, though can be larger
Diagnostic Features
Imaging Characteristics
Ultrasound: Solid, round, well-circumscribed masses with homogeneous echogenicity, often with:
- Oval or round shape
- Abrupt well-defined margins
- Orientation parallel to the chest wall
- No posterior acoustic shadowing 3
Mammography: Well-circumscribed, round or oval masses, sometimes with lobulated features 1
Classification
Fibroadenomas can be classified as:
- Simple: Most common type
- Complex: Contains cysts >3 mm, epithelial calcifications, sclerosing adenosis, or papillary apocrine metaplasia
- Giant: >5 cm in diameter or >500 grams
- Juvenile/Myxoid: Occurs in adolescents 1, 2
Diagnosis and Management
Diagnostic Approach
The triple test is essential for accurate diagnosis:
- Clinical examination
- Imaging (ultrasound for younger women; ultrasound plus mammography for older women)
- Tissue sampling (fine needle aspiration or core biopsy) 4
Management Options
For typical fibroadenomas with benign features confirmed by the triple test, observation is appropriate and surgical excision is not routinely necessary. 3
Indications for surgical intervention include:
- Diameter >2 cm
- Rapid growth
- Complex features on imaging
- Patient symptoms or anxiety
- Diagnostic uncertainty
- Need to exclude phyllodes tumor 1
Important Distinctions
- Phyllodes Tumor vs. Fibroadenoma:
Risk of Malignancy
The risk of malignancy in or adjacent to a fibroadenoma is very low (approximately 0.58% in core biopsied nodules) 5. The risk of cancer in a growing fibroadenoma is even rarer, with studies showing negligible incidence of malignant transformation 5.
Follow-up Recommendations
- Fibroadenomas without epithelial abnormalities diagnosed by core biopsy generally require no specific follow-up due to the negligible risk of malignant transformation 5
- For fibroadenomas managed conservatively, patients should be informed about the limitations of diagnostic tests and advised to seek prompt assessment if there are symptomatic or clinical changes 4
Common Pitfalls and Caveats
Diagnostic Uncertainty: A clinical diagnosis alone is unreliable and does not exclude malignancy, even in younger women 4
Distinguishing from Phyllodes Tumors: Large or rapidly growing fibroadenomas may be difficult to distinguish from phyllodes tumors, which require different management 3
Pregnancy-Associated Growth: Fibroadenomas may rapidly enlarge during pregnancy due to hormonal changes, sometimes requiring intervention to prevent permanent breast tissue damage 2
Complex Fibroadenomas: These require more careful evaluation as they may have slightly higher associated risk